image credit: Pixabay

Opioid Suits Loom Over A Walgreens-AmerisourceBergen Deal

May 21, 2019

Via: Forbes

The potential for drug distributor AmerisourceBergen to be a part of a major opioid-related settlement may be reason enough for Walgreens Boots Alliance to stay away from buying all of the company.

There’s increasing speculation that Walgreens may spend billions of dollars buying the remaining stake in AmerisourceBergen that the drugstore giant doesn’t already own as investors and some Wall Street analysts look for a bigger deal from the global retail pharmacy giant.

Read More on Forbes